Rationale: In recent decades, diagnosis and treatment recommendations for idiopathic
pulmonary fibrosis (IPF) have changed. In Korea, the average life expectancy has increased …

Background Idiopathic pulmonary fibrosis (IPF) is a serious interstitial lung disease (ILD)
with a median survival of 3-5 years. The aim of the present study was to evaluate disease …

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a common subtype of interstitial lung
disease (ILD). Information about the associated comorbidities and predictors of survival …

Background There are substantial advances in diagnosis and treatment for idiopathic
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …

Objective Create a timeline of diagnosis and treatment for IPF in the US. Design, setting, and
participants A retrospective analysis was performed in collaboration with the OptumLabs …

In addition to facilitating healthcare delivery planning, reliable information about prognosis is
essential for treatment decisions in patients with idiopathic pulmonary fibrosis (IPF). This …

PURPOSE: IPF is a progressive fibrosing interstitial lung disease characterized by loss of
lung function, dyspnea and cough, and high mortality. The Idiopathic Pulmonary Fibrosis …

Background Idiopathic pulmonary fibrosis (IPF) is frequently accompanied by comorbidities,
with the management of these comorbidities crucial for clinical outcomes. This study …

In patients with idiopathic pulmonary fibrosis (IPF), the effects of antifibrotic agents on the
prognosis remain unclear. This study aimed to investigate the impact of antifibrotic treatment …

The American Thoracic Society and European Respiratory Society guidelines for the
diagnosis and treatment of idiopathic pulmonary fibrosis (IPF) have been published recently …